期刊
ACS CHEMICAL NEUROSCIENCE
卷 4, 期 4, 页码 624-634出版社
AMER CHEMICAL SOC
DOI: 10.1021/cn300233v
关键词
TRPV1; positron emission tomography; carbon-11; fluorine-18; I-123-RTX
资金
- Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT)
- in vivo molecular imaging research (IMIR)
- Intramural Research Program, National Institutes of Health, National Cancer Institute, Center for Cancer Research [Z1A BC 005270]
The transient receptor potential vanilloid subfamily member 1 (TRPV1) cation channel is known to be involved in pain nociception and neurogenic inflammation, and accumulating evidence suggests that it plays an important role in several central nervous system (CNS)-related disorders. TRPV1-specific positron emission tomography (PET) radioligands can serve as powerful tools in TRPV1-related (pre)clinical research and drug design. We have synthesized several potent TRPV1 antagonists and accompanying precursors for radiolabeling with carbon-11 or fluorine-18. The cinnamic acid derivative [C-11]DVV24 and the aminoquinazoline [F-18]DVV54 were successfully synthesized, and their biological behavior was studied. In addition, the in vivo behavior of a I-123-labeled analogue of iodo-resiniferatoxin (I-RTX), a well-known TRPV1 antagonist, was evaluated. The binding affinities of DVV24 and DVV54 for human TRPV1 were 163 +/- 28 and 171 +/- 48 nM, respectively. [C-11]DVV24, but not [F-18]DVV54 or I-123-RTX, showed retention in the trigeminal nerve, known to abundantly express TRPV1. Nevertheless, it appears that ligands with higher binding affinities will be required to allow in vivo imaging of TRPV1 via PET.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据